Healthcare provider profile · identity verified

Heather M. Burney, MD

Family Practice · CHARLOTTE, NC · NPI 1013093939

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	426	110
Amlodipine Besylate	Amlodipine Besylate	342	100
Lisinopril	Lisinopril	195	63
Omeprazole	Omeprazole	153	40
Gabapentin	Gabapentin	138	40
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	134	44
Furosemide	Furosemide	129	33
Metformin Hcl Er	Metformin Hcl	126	36
Losartan Potassium	Losartan Potassium	110	33
Fluticasone Propionate	Fluticasone Propionate	104	35
Carvedilol	Carvedilol	102	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	98	25
Potassium Chloride	Potassium Chloride	96	27
Rosuvastatin Calcium	Rosuvastatin Calcium	96	36
Albuterol Sulfate Hfa	Albuterol Sulfate	88	30
Metoprolol Succinate	Metoprolol Succinate	80	26
Pantoprazole Sodium	Pantoprazole Sodium	75	19
Jardiance	Empagliflozin	71	23
Ozempic	Semaglutide	71	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	19
Tramadol Hcl	Tramadol Hcl	63	12
Diclofenac Sodium	Diclofenac Sodium	56	18
Famotidine	Famotidine	55	16
Trazodone Hcl	Trazodone Hcl	55	15
Levothyroxine Sodium	Levothyroxine Sodium	52	14
Trulicity	Dulaglutide	45	suppressed
Clopidogrel	Clopidogrel Bisulfate	42	15
Montelukast Sodium	Montelukast Sodium	42	18
Spironolactone	Spironolactone	42	14
Duloxetine Hcl	Duloxetine Hcl	41	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	suppressed
Metformin Hcl	Metformin Hcl	41	12
Metoprolol Tartrate	Metoprolol Tartrate	40	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	12
Oxybutynin Chloride Er	Oxybutynin Chloride	38	suppressed
Eliquis	Apixaban	36	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	36	12
Mounjaro	Tirzepatide	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Atenolol	Atenolol	28	suppressed
Clonidine	Clonidine	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Pregabalin	Pregabalin	28	11
Tamsulosin Hcl	Tamsulosin Hcl	27	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Meloxicam	Meloxicam	25	12
Entresto	Sacubitril/Valsartan	22	suppressed
Simvastatin	Simvastatin	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Valsartan	Valsartan	20	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Ibu	Ibuprofen	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	18	suppressed
Glipizide Er	Glipizide	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Allopurinol	Allopurinol	14	suppressed
Baclofen	Baclofen	14	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Embrace Pen Needle	Pen Needle, Diabetic	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error